Press "Enter" to skip to content

Sanofi wins FDA approval to sell dengue shot in parts of U.S.

The U.S. Food and Drug Administration on Wednesday approved Sanofi SA’s dengue vaccine Dengvaxia for use in the United States among people aged 9 through 16 who have laboratory-confirmed previous dengue infection and live in endemic areas. (

Original source:

Also Read:   Ebola spread concentrated in Congo, not a wider emergency: WHO